Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers



Status:Recruiting
Conditions:Gastrointestinal, Podiatry, Diabetes
Therapuetic Areas:Endocrinology, Gastroenterology, Orthopedics / Podiatry
Healthy:No
Age Range:18 - 80
Updated:11/3/2018
Start Date:January 2017
End Date:December 2019
Contact:Sheila Yi
Email:sheila@viromed.co.kr

Use our guide to learn which trials are right for you!

A Phase III, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Asses the Safety and Efficacy of VM202 to Treat Chronic Nonhealing Foot Ulcers in Diabetic Patients With Concomitant Peripheral Arterial Disease (PAD)

This study will assess the safety and efficacy of using gene therapy via intramuscular
injections of the calf for patients with chronic non-healing foot ulcers.

A phase III, randomized, double-blind, placebo-controlled, multicenter, 7-month study
designed to assess the safety and efficacy of intramuscular (IM) injections in the calf of
VM202 in patients with chronic nonhealing foot ulcers. Three hundred patients will be
randomized in a 2:1 ratio of VM202 or placebo injections:

- Active -VM202 + standard of care - 200 patients

- Control - Placebo (VM202 Vehicle) + standard of care - 100 patients

Inclusion Criteria:

- Documented symptomatic PAD

- Documented history of Type I or II diabetes with current treatment control (HbA1c of ≤
12.0% at Screening) and currently on oral medication and / or insulin

- No significant changes anticipated in diabetes medication regimen

- At Screening, subject has one ulcer on the target foot

- Subjects will undergo protocol-defined standardized wound care during screening (for
two weeks or longer).

Exclusion Criteria:

- Will require revascularization in the target leg within 3 months of randomization

- In the investigator's assessment, will require an amputation in the target leg within
3 months of randomization

- Subject diagnosed with critical limb ischemia (CLI; Rutherford score ≥ 4)

- Evidence of active infection (e.g., cellulitis, osteomyelitis) or deep ulceration
exposing bone or tendon in the foot planned for treatment

- Current fracture in the target foot

- Heart Failure with a New York Heart Association (NYHA) classification of III or IV;

- Body mass index (BMI) > 45 kg/m2 at Screening

- Unstable angina
We found this trial at
22
sites
Las Vegas, Nevada 89119
Principal Investigator: Cyaandi Dove, DPM
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Birmingham, Alabama 35205
Principal Investigator: Jeffrey Davis, MD
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Carmichael, California 95608
Principal Investigator: Gregory Tovmassian, DPM
?
mi
from
Carmichael, CA
Click here to add this to my saved trials
Castro Valley, California 94546
Principal Investigator: Mher Vartivarian, DPM
?
mi
from
Castro Valley, CA
Click here to add this to my saved trials
303 East Superior Street
Chicago, Illinois 60611
Principal Investigator: Karen Ho, MD
?
mi
from
Chicago, IL
Click here to add this to my saved trials
El Paso, Texas 79935
Principal Investigator: Gil M Moreu, DPM
?
mi
from
El Paso, TX
Click here to add this to my saved trials
Eugene, Oregon 97401
Principal Investigator: Lacey Loveland, DPM
?
mi
from
Eugene, OR
Click here to add this to my saved trials
Fort Worth, Texas 76107
Principal Investigator: Travis Motley, DPM
?
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Houston, Texas 77225
Principal Investigator: Emerson Perin, MD
?
mi
from
Houston, TX
Click here to add this to my saved trials
Jonesboro, Arkansas 72401
Principal Investigator: Christopher Rowlett, DPM
?
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Long Beach, California 90822
Principal Investigator: Ian Gordon, MD
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
Los Angeles, California 90010
Principal Investigator: Felix Sigal, DPM
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Los Angeles, California 90033
Principal Investigator: David Armstrong
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
McAllen, Texas 78501
Principal Investigator: Joseph Caporusso, DPM
?
mi
from
McAllen, TX
Click here to add this to my saved trials
Miami, Florida 33126
Principal Investigator: Jacob Silverstone, DPM
?
mi
from
Miami, FL
Click here to add this to my saved trials
286 Westward Drive
Miami, Florida 33176
Principal Investigator: Francisco Oliva, DPM
?
mi
from
Miami, FL
Click here to add this to my saved trials
Phoenix, Arizona 85023
Principal Investigator: Joseph Gimbel, MD
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Saint Louis, Missouri 63110
Principal Investigator: Catherine Wittgen, MD
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
San Francisco, California 94115
Principal Investigator: Alexander Reyzelman, DPM
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
14445 Olive View Drive
Sylmar, California 91342
Principal Investigator: Aksone Nouvong, DPM
?
mi
from
Sylmar, CA
Click here to add this to my saved trials
Tucson, Arizona 85721
(520) 621-2211
Principal Investigator: Eric Espensen, DPM
University of Arizona The University of Arizona is a premier, public research university. Established in...
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
Worcester, Massachusetts 01605
Principal Investigator: Edward Arous, MD
?
mi
from
Worcester, MA
Click here to add this to my saved trials